Clarivate (NYSE:CLVT – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01), Zacks reports. Clarivate had a negative net margin of 50.00% and a positive return on equity of 9.69%. Clarivate updated its FY 2025 guidance to 0.600-0.700 EPS.
Clarivate Trading Down 4.7 %
NYSE CLVT opened at $4.61 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.88 and a current ratio of 0.88. The firm has a market cap of $3.27 billion, a PE ratio of -2.30 and a beta of 1.17. Clarivate has a one year low of $4.25 and a one year high of $9.07. The firm’s fifty day moving average is $5.15 and its two-hundred day moving average is $5.82.
Clarivate declared that its board has approved a share repurchase plan on Monday, December 16th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 12.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.
Insider Buying and Selling at Clarivate
Analysts Set New Price Targets
Several equities research analysts recently commented on the stock. Royal Bank of Canada cut their price target on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research note on Thursday, November 7th. William Blair lowered shares of Clarivate from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 6th. Finally, Barclays cut their price target on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research note on Thursday, November 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Clarivate has an average rating of “Hold” and an average price target of $7.10.
Get Our Latest Stock Report on Clarivate
About Clarivate
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
- Five stocks we like better than Clarivate
- What Investors Need to Know About Upcoming IPOs
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- Where to Find Earnings Call Transcripts
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- The 3 Best Fintech Stocks to Buy Now
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.